Skip to main content
. 2022 Aug 30;149(7):4131–4139. doi: 10.1007/s00432-022-04329-y

Fig. 1.

Fig. 1

Expression of selected markers on tumor-associated immune cells in venous tumor thrombus and primary RCC. VISTA and TOX in tumor thrombus A and primary tumor B, PD-L1 and TOX in tumor thrombus C, comparison of VISTA expression between compartments D – lines connect corresponding cases. PD-L1 programmed death-ligand 1, TAICs tumor-associated immune cells, TOX thymocyte selection-associated HMG BOX, VISTA V-domain Ig suppressor of T cell activation. The associations were estimated with the Wilcoxon test